Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Vinney George"'
Autor:
Joy G. Ghosh, Andrew A. Nguyen, Chad E. Bigelow, Stephen Poor, Yubin Qiu, Nalini Rangaswamy, Richard Ornberg, Brittany Jackson, Howard Mak, Tucker Ezell, Vania Kenanova, Elisa de la Cruz, Ana Carrion, Bijan Etemad-Gilbertson, Roxana Garcia Caro, Kan Zhu, Vinney George, Jirong Bai, Radhika Sharma-Nahar, Siyuan Shen, Yiqin Wang, Kulandayan K. Subramanian, Elizabeth Fassbender, Michael Maker, Shawn Hanks, Joanna Vrouvlianis, Barrett Leehy, Debby Long, Melissa Prentiss, Viral Kansara, Bruce Jaffee, Thaddeus P. Dryja, Michael Roguska
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-10 (2017)
Retinal vascular disease treatments involve frequent pharmacological intraocular administrations. Here the authors present a method to increase the half-life of injected drugs by fusing these to a hyaluronan-binding peptide, which might lead to less
Externí odkaz:
https://doaj.org/article/f0adf43d440f4267b734d5d4506d7186
Autor:
Ana Carrion, Debby Long, Andrew Anh Nguyen, Michael Roguska, Elisa de la Cruz, Bruce D Jaffee, Stephen Poor, Kulandayan K. Subramanian, Bijan Etemad-Gilbertson, Vania Kenanova, Shawn Hanks, Roxana Garcia Caro, Nalini Rangaswamy, Kan Zhu, Barrett Leehy, Elizabeth Fassbender, Chad E Bigelow, Howard H. Mak, Joy Ghosh, Jirong Bai, Yubin Qiu, Viral Kansara, Radhika Sharma-Nahar, Siyuan Shen, Michael Maker, Melissa Prentiss, Brittany Jackson, Richard Ornberg, Joanna Vrouvlianis, Vinney George, Yiqin Wang, Tucker Ezell, Thaddeus P. Dryja
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-10 (2017)
Nature Communications
Nature Communications
Protein drugs that neutralize vascular endothelial growth factor (VEGF), such as aflibercept or ranibizumab, rescue vision in patients with retinal vascular diseases. Nonetheless, optimal visual outcomes require intraocular injections as frequently a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70f28f1f2760d443ab436000b8e2eab1
https://doaj.org/article/f0adf43d440f4267b734d5d4506d7186
https://doaj.org/article/f0adf43d440f4267b734d5d4506d7186